Weak Q4 may be rare bitter pill for Sun Pharma
Sun Pharmaceutical Industries reported a 34 per cent year-on-year (Y-o-Y) jump in net profit to Rs 2,654.6 crore in Q4FY24.
Stay updated with breaking news from Taro Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sun Pharmaceutical Industries reported a 34 per cent year-on-year (Y-o-Y) jump in net profit to Rs 2,654.6 crore in Q4FY24.
Sanjiv Bhasin advises caution on Bhel stock due to parabolic rise, suggests focusing on rail stocks instead for investment opportunities. Bhasin says we would say be a little cautious, wait out, hear the commentary and let some corrections come in because now you are chasing a parabolic rise which may not last for long.
India Business News: Sun Pharma announces the acquisition of the remaining stake in its subsidiary Taro for $348 million. Find out more about this strategic move and its impact on the pharmaceutical industry.
Sun Pharma’s efforts to mop up the remaining shares in Israel’s Taro Pharma have reached the final stage with the two companies
Libra Merger Ltd is Sun’s second buy in Israel after Taro Pharma, a high-profile acquisition for the Indian drug company